EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

The complex molecular mechanisms that drive endothelial cell movement and the formation of new vessels are poorly understood and require further investigation. Eph receptor tyrosine kinases and their membrane-anchored ephrin ligands regulate cell movements mostly by cell-cell contact, whereas the G-protein-coupled receptor CXCR4 and its unique SDF-1 chemokine ligand regulate cell movement mostly through soluble gradients. By using biochemical and functional approaches, we investigated how ephrinB and SDF-1 orchestrate endothelial cell movement and morphogenesis into capillary-like structures. We describe how endogenous EphB2 and EphB4 signaling are required for the formation of extracellular matrix-dependent capillary-like structures in primary human endothelial cells. We further demonstrate that EphB2 and EphB4 activation enhance SDF-1-induced signaling and chemotaxis that are also required for extracellular matrix-dependent endothelial cell clustering. These results support a model in which SDF-1 gradients first promote endothelial cell clustering and then EphB2 and EphB4 critically contribute to subsequent cell movement and alignment into cord-like structures. This study reveals a requirement for endogenous Eph signaling in endothelial cell morphogenic processes, uncovers a novel link between EphB forward signaling and SDF-1-induced signaling, and demonstrates a mechanism for cooperative regulation of endothelial cell movement.

[1]  R. Taichman,et al.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. , 2000, The Journal of clinical investigation.

[2]  H. Kanetake,et al.  Stromal cell-derived factor-1alpha induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. , 2003, The Journal of biological chemistry.

[3]  M. Zimmer,et al.  EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. , 2002, Molecular cell.

[4]  I. Clark-lewis,et al.  Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. , 2000 .

[5]  H. Kanetake,et al.  Stromal Cell-derived Factor-1α Induces Tube-like Structure Formation of Endothelial Cells through Phosphoinositide 3-Kinase* , 2003, The Journal of Biological Chemistry.

[6]  Kouji Matsushima,et al.  The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract , 1998, Nature.

[7]  S. Pittaluga,et al.  Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. , 2003, Blood.

[8]  A. Lane,et al.  Surface densities of ephrin‐B1 determine EphB1‐coupled activation of cell attachment through αvβ3 and α5β1 integrins , 1999 .

[9]  C. Turner,et al.  EphB1-mediated Cell Migration Requires the Phosphorylation of Paxillin at Tyr-31/Tyr-118* , 2004, Journal of Biological Chemistry.

[10]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[11]  Elena B Pasquale,et al.  EphB Receptor-binding Peptides Identified by Phage Display Enable Design of an Antagonist with Ephrin-like Affinity* , 2005, Journal of Biological Chemistry.

[12]  A. Harris,et al.  Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. , 2006, Blood.

[13]  David J. Anderson,et al.  Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4 , 1998, Cell.

[14]  E. Pasquale,et al.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Chad A. Cowan,et al.  The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals , 2001, Nature.

[16]  E. Pasquale,et al.  Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. , 2004, Cellular signalling.

[17]  Guoyao Wu,et al.  Eph B4 Receptor Signaling Mediates Endothelial Cell Migration and Proliferation via the Phosphatidylinositol 3-Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[18]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[19]  D. Anderson,et al.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. , 1999, Molecular cell.

[20]  A. Pandey,et al.  Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. , 1995, Science.

[21]  N. Prévost,et al.  Contact‐dependent signaling during the late events of platelet activation , 2003, Journal of thrombosis and haemostasis : JTH.

[22]  T. Springer,et al.  The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. , 1999, Immunity.

[23]  A. Amara,et al.  Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. , 1999, The American journal of pathology.

[24]  R. Adams,et al.  Ephrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly , 2006, Cell.

[25]  A. Angiolillo,et al.  Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells. , 1995, Leukemia & lymphoma.

[26]  Elena B. Pasquale,et al.  Developmental cell biology: Eph receptor signalling casts a wide net on cell behaviour , 2005, Nature Reviews Molecular Cell Biology.

[27]  Paul Polakis,et al.  EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer , 2004, Cancer Research.

[28]  Lei Yao,et al.  Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. , 2002, Blood.

[29]  F. Diella,et al.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. , 1999, Genes & development.

[30]  M. Krasnow,et al.  Tube Morphogenesis Making and Shaping Biological Tubes , 2003, Cell.

[31]  M. E. Robinson,et al.  Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Klein,et al.  Altered Expression Patterns of EphrinB2 and EphB2 in Human Umbilical Vessels and Congenital Venous Malformations , 2005, Pediatric Research.

[33]  T. Suda,et al.  Ephrin-B2 Induces Migration of Endothelial Cells Through the Phosphatidylinositol-3 Kinase Pathway and Promotes Angiogenesis in Adult Vasculature , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Chen Li,et al.  Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling , 2004, Nature Neuroscience.

[35]  R. Klein,et al.  Ephrin-B Reverse Signaling Is Mediated by a Novel PDZ-RGS Protein and Selectively Inhibits G Protein–Coupled Chemoattraction , 2001, Cell.

[36]  H. Kleinman,et al.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. , 1999, The American journal of pathology.

[37]  J G Flanagan,et al.  The ephrins and Eph receptors in neural development. , 1998, Annual review of neuroscience.

[38]  A. Lane,et al.  Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. , 1998, Genes & development.

[39]  A. Lane,et al.  Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. , 1999, The EMBO journal.

[40]  F. Bonhoeffer,et al.  On the turning of Xenopus retinal axons induced by ephrin-A5 , 2003, Development.

[41]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[42]  J A Biegel,et al.  Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family. , 1995, Human molecular genetics.

[43]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[44]  J. García-Verdugo,et al.  Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone , 2000, Nature Neuroscience.

[45]  A. Iwama,et al.  Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. , 1996, Oncogene.

[46]  P. Kuhn,et al.  Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. , 2006, Structure.

[47]  E. Pasquale Eph–ephrin promiscuity is now crystal clear , 2004, Nature Neuroscience.

[48]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[49]  Gudrun Dandekar,et al.  Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells , 2003, Journal of Cell Science.

[50]  N. Yamamoto,et al.  Ephrin‐B3–EphA4 interactions regulate the growth of specific thalamocortical axon populations in vitro , 2002, The European journal of neuroscience.

[51]  B. Weinstein Vessels and Nerves: Marching to the Same Tune , 2005, Cell.

[52]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[53]  Dana M. Brantley-Sieders,et al.  EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation , 2004, Journal of Cell Science.

[54]  Edward J. Fuchs,et al.  Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers , 2000, Antimicrobial Agents and Chemotherapy.

[55]  G. Yancopoulos,et al.  EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Peter Carmeliet,et al.  Guidance of vascular and neural network formation , 2005, Current Opinion in Neurobiology.

[58]  M. Matsuda,et al.  Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. , 2002, Molecular biology of the cell.

[59]  M. Kinch,et al.  Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation , 2000, Nature Cell Biology.

[60]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[61]  D. Sretavan,et al.  L1/Laminin Modulation of Growth Cone Response to EphB Triggers Growth Pauses and Regulates the Microtubule Destabilizing Protein SCG10 , 2004, The Journal of Neuroscience.

[62]  T. Daniel,et al.  Identification of a subpopulation of human renal microvascular endothelial cells with capacity to form capillary-like cord and tube structures , 1997, In Vitro Cellular & Developmental Biology - Animal.

[63]  K. Murai,et al.  `Eph'ective signaling: forward, reverse and crosstalk , 2003, Journal of Cell Science.

[64]  O. Fernandez-Capetillo,et al.  Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. , 2005, Blood.